Drawing for VIDARX . THIS IS FOR A TELEMEDICINE PLATFORM THAT IS DESIGNED TO CONNECT PATIENTS TO A PROVIDER / PHARMACY, AND SERVE BILLINGUAL (SPANISH / ENGLISH) PATIENTS FOR MEDICATIONS.

USPTO serial 50086421

VIDARX . THIS IS FOR A TELEMEDICINE PLATFORM THAT IS DESIGNED TO CONNECT PATIENTS TO A PROVIDER / PHARMACY, AND SERVE BILLINGUAL (SPANISH / ENGLISH) PATIENTS FOR MEDICATIONS.

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with VIDARX . THIS IS FOR A TELEMEDICINE PLATFORM THAT IS DESIGNED TO CONNECT PATIENTS TO A PROVIDER / PHARMACY, AND SERVE BILLINGUAL (SPANISH / ENGLISH) PATIENTS FOR MEDICATIONS.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
044Telemedicine servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 2, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance